
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Dec 08, 2025 03:00 am UTC| Business Health
Eli Lillys diabetes drug Mounjaro is set to join Chinas state-run health insurance reimbursement list on January 1, according to the National Healthcare Security Administration. The move is expected to significantly expand...

U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Dec 07, 2025 00:57 am UTC| Politics Health
The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwandas healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the...

Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Dec 06, 2025 01:50 am UTC| Politics Health
President Donald Trump on Friday expressed support for a major shift in U.S. vaccine policy after government advisers voted to eliminate the long-standing recommendation that all newborns receive the hepatitis B vaccine at...

FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Dec 04, 2025 06:31 am UTC| Governance Health
The U.S. Food and Drug Administration has appointed Tracy Beth Høeg as the acting director of the Center for Drug Evaluation and Research (CDER), stepping in shortly after Richard Pazdur revealed he will retire only...

U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Dec 02, 2025 02:06 am UTC| Business Politics Law Health
The Trump administration has thrown its support behind Bayer as the company urges the U.S. Supreme Court to review thousands of lawsuits alleging its Roundup weedkiller causes cancer. In a filing submitted by U.S....

FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths
Nov 30, 2025 00:12 am UTC| Politics Health Governance
A newly surfaced internal memo from the U.S. Food and Drug Administration (FDA) has sparked debate after chief medical and scientific officer Vinay Prasad stated that COVID-19 vaccinations may have contributed to at least...

Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Nov 24, 2025 09:43 am UTC| Business Health
Bayers experimental stroke treatment, asundexian, delivered strong results in the Phase III OCEANIC-STROKE trial, prompting renewed optimism for the pharmaceutical giant. Analysts, including Goldman Sachs James Quigley,...